Home › NDC Lookup › RxCUI directory › RxCUI 859835

Fluphenazine hydrochloride 0.5 MG/ML Oral Solution — RxCUI 859835

RxNorm drug concept · Semantic clinical drug
RxCUI 859835 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI859835
Official nameFluphenazine hydrochloride 0.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluphenazine HCl 2.5 MG per 5 ML Oral Solution; fluPHENAZine HCl 2.5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluphenazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fluphenazine is an antipsychotic medication used to manage psychotic disorders — most commonly schizophrenia. It's available as tablets, an oral liquid, and injections. The long-ac...
  • Fluphenazine Decanoate Injection is chemically designed to release slowly after a single shot, so one injection can keep working for up to four weeks or even longer. The regular ta...
  • How is the long-acting injection different from the tablets or regular shot?
  • The most common side effects involve movement — things like muscle stiffness, a restless, fidgety feeling, or tremors. These can often be managed by adjusting your dose or adding a...
📖 Read our full Fluphenazine guide →

🕸️ Concept Web — How Fluphenazine hydrochloride 0.5 MG/ML Oral Soluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluphenazine hydrochloride 0.5 MG/ML Oral Solution RxCUI 859835

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Fluphenazine 4496
    • Fluphenazine hydrochloride 203207
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluphenazine Oral Solution 372239
    • Fluphenazine hydrochloride Oral Solution 2647768
    • Fluphenazine Oral Liquid Product 1161442
    • Fluphenazine Oral Product 1161443
    • Fluphenazine hydrochloride Oral Liquid Product 2662761
    • Fluphenazine hydrochloride Oral Product 2663299
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fluphenazine hydrochloride 0.5 MG/ML 859834

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluphenazine hydrochloride 0.5 MG/ML SCDC · 859834
  • Fluphenazine Oral Solution SCDF · 372239
  • Fluphenazine hydrochloride Oral Solution SCDFP · 2647768
  • Fluphenazine Oral Liquid Product SCDG · 1161442
  • Fluphenazine Oral Product SCDG · 1161443
  • Fluphenazine hydrochloride Oral Liquid Product SCDGP · 2662761
  • Fluphenazine hydrochloride Oral Product SCDGP · 2663299

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 859835 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0654-02 60 mL in 1 BOTTLE (0121-0654-02) Fluphenazine Hydrochloride PAI Holdings, LLC dba PAI Pharma 2010-08-31
00121-0654-16 473 mL in 1 BOTTLE (0121-0654-16) Fluphenazine Hydrochloride PAI Holdings, LLC dba PAI Pharma 2010-08-31
Observed labelers: PAI Holdings, LLC dba PAI Pharma (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.